Voltaire Acquired By Mellanox Technologies

Davis Polk is advising Bank of America Merrill Lynch as financial adviser to Voltaire Ltd. in connection with its $8.75 per share, or a total equity value of approximately $218 million ($176 million net of cash), acquisition by Mellanox Technologies, Ltd. The transaction, which is expected to close in the first quarter of 2011, is subject to customary closing conditions, including the receipt of applicable regulatory approvals and the approval of Voltaire’s shareholders.

More >>

Simpson Thacher Represents Wireless Generation Inc. in its Proposed $360 Million Sale to the News Corporation

The Firm is representing Wireless Generation Inc. in connection with its proposed $360 million sale to the News Corporation.  Wireless Generation provides mobile and web software, data systems and professional services that enable teachers to use data to assess student progress and deliver individualized instruction, serving more than 200,000 teachers and three million students across all 50 states.  News Corporation is a diversified global media company. 

More >>

Tags:  Simpson Thacher & Bartlett LLP

Andrews Kurth Represents IDB in $140 Million Syndicated Loan to Brazil’s Banco Sofisa

On November 23, 2010, the Inter-American Development Bank (“IDB”) closed on a syndicated dual currency (US$115 million and €18 million) A/B loan to Brazil’s Banco Sofisa. The proceeds of the loan are to be used to increase lending to small- and medium-sized enterprises in Brazil. The syndication to some 15 U.S., Brazilian and European banks was co-arranged by IDB and Banco Itau, with HSBC, Banco do Brasil and Standard Bank as bookrunners. The transaction involves a five-year IDB $25 million A loan and a syndicated B loan composed of four tranches: two denominated in U.S. dollars for a total amount of $90 million, and two denominated in Euros for a total amount of €18.6 million. The syndicated loans mature in two and three years.

More >>

Tags:  

Morgan Lewis Advises Eurand on $583 Million Acquisition by Axcan Holdings

Today, Eurand N.V. and Axcan Holdings, Inc. announced they have entered into a definitive agreement whereby Axcan will acquire all outstanding shares of Eurand for $12.00 per share in cash, or approximately $583 million. Eurand is a global specialty pharmaceutical company and Axcan is a pharmaceutical company that focuses on the treatment of gastrointestinal disorders.

More >>

Tags:  Morgan Lewis & Bockius LLP